OtherClinical Investigations (Human)
Initial studies with [11C]vorozole positron emission tomography detect over-expression of intra-tumoral aromatase in breast cancer
Anat Biegon, Kenneth R. Shroyer, Dinko Franceschi, Jasbeer Dhawan, Mouna Tahmi, Deborah Pareto, Patrick Bonilla, Krystal Airola and Jules Cohen
Journal of Nuclear Medicine November 2019, jnumed.119.231589; DOI: https://doi.org/10.2967/jnumed.119.231589
Anat Biegon
1 Stony Brook University School of Medicine, United States;
Kenneth R. Shroyer
1 Stony Brook University School of Medicine, United States;
Dinko Franceschi
2 Stony Brook University, United States;
Jasbeer Dhawan
1 Stony Brook University School of Medicine, United States;
Mouna Tahmi
1 Stony Brook University School of Medicine, United States;
Deborah Pareto
3 Val d'Hebron Hospital, Spain;
Patrick Bonilla
4 Nassau University Medical Center
Krystal Airola
1 Stony Brook University School of Medicine, United States;
Jules Cohen
1 Stony Brook University School of Medicine, United States;
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
Initial studies with [11C]vorozole positron emission tomography detect over-expression of intra-tumoral aromatase in breast cancer
Anat Biegon, Kenneth R. Shroyer, Dinko Franceschi, Jasbeer Dhawan, Mouna Tahmi, Deborah Pareto, Patrick Bonilla, Krystal Airola, Jules Cohen
Journal of Nuclear Medicine Nov 2019, jnumed.119.231589; DOI: 10.2967/jnumed.119.231589
Initial studies with [11C]vorozole positron emission tomography detect over-expression of intra-tumoral aromatase in breast cancer
Anat Biegon, Kenneth R. Shroyer, Dinko Franceschi, Jasbeer Dhawan, Mouna Tahmi, Deborah Pareto, Patrick Bonilla, Krystal Airola, Jules Cohen
Journal of Nuclear Medicine Nov 2019, jnumed.119.231589; DOI: 10.2967/jnumed.119.231589